Osteosarcoma Institute

Analysis

Osteosarcoma Institute is a registered charity in United States, based in Dallas, TX. It received its IRS tax-exemption ruling in May 2018, 8 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Osteosarcoma Institute reported income of $1.4m and spending of $2.7m, spending 201% of what it took in. Across the 5 years on record, from December 2019 to December 2023, income grew from $376k to $1.4m (+264%), an average of +38% a year. The sharpest change came in the year to December 2022, when income rose by 156%. Over the whole period it spent 230% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Osteosarcoma Institute sits at the 68th percentile: it is larger than about 68% of them. Against every charity in United States with reported income it ranks in the 83rd percentile, and in the 86th percentile within TX. Charities of a similar size with the same main cause include Gingerbread House ($1.4m), Lets Win Pancreatic Cancer Foundation ($1.4m) and Schizophrenia International Research Society Inc ($1.4m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 92% of the total. Compensation of current officers, directors and key employees was $241k (8.8% of expenses). Other salaries and wages came to $307k. At year end it held assets of $4.8m against liabilities of $45k, net assets of $4.7m. It reported 6 employees.

Data notes from the register: Spending has exceeded income in each of the last three reported years, so the charity has been drawing on reserves or other funds.